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with respect to the calcium phosphate solid phase. Fifteen ofCalcium phosphate supersaturation regulates stone formation
the 20 kidneys from the 10 rats fed the high-phosphorus dietin genetic hypercalciuric stone-forming rats.
had radiographic evidence of kidney stone formation, whereasBackground. Hypercalciuria is the most common metabolic
no kidneys from the rats fed either the medium- or low-phos-abnormality observed in patients with nephrolithiasis. Hyper-
phorus diet developed kidney stones.calciuria raises urine supersaturation with respect to the solid
phases of calcium oxalate and calcium phosphate, leading to Conclusions. A decrease in urine phosphorus excretion not
an enhanced probability for nucleation and growth of crystals only led to a decrease in urine supersaturation with respect to
into clinically significant stones. However, there is little direct the calcium phosphate solid phase but to an elimination of
proof that supersaturation itself regulates stone formation. renal stone formation. The results of this study support the
Through successive inbreeding of the most hypercalciuric prog- hypothesis that variation in supersaturation alone can regulate
eny of hypercalciuric Sprague-Dawley rats, we have established renal stone formation. Whether a reduction of dietary phospho-
a strain of rats, each of which excrete abnormally large amounts rus will alter stone formation in humans with calcium phos-
of urinary calcium and each of which forms calcium phosphate phate nephrolithiasis remains to be determined.
kidney stones. We used these hypercalciuric (GHS) rats to test
the hypothesis that an isolated reduction in urine supersatura-
tion, achieved by decreasing urine phosphorus excretion, would
Hypercalciuria is the most common metabolic abnor-decrease stone formation in these rats.
Methods. Thirty 44th-generation female GHS rats were ran- mality in patients with nephrolithiasis [1–5]. Hypercalci-
domly divided into three groups. Ten rats received a high- uria raises urine supersaturation with respect to the solid
phosphorus diet (0.565% phosphorus), 10 a medium-phospho- phases of calcium oxalate and calcium phosphate, en-rus diet (0.395% phosphorus), and 10 a low-phosphorus diet
hancing the probability of nucleation and growth of crys-(0.225% phosphorus) for a total of 18 weeks. The lowered
tals into clinically significant stones [2]. The reversal ofdietary phosphorus would be expected to result in a decrease
in urine phosphorus excretion and a decrease in urinary super- the hypercalciuria with consequent lowering of supersat-
saturation with respect to the calcium phosphate solid phase. uration with thiazide diuretics has been shown to reduce
Every two weeks, 24-hour urine collections were obtained. All
clinical stone formation in two long-term studies [6, 7]. Inrelevant ions were measured, and supersaturation with respect
addition to the hypocalciuric action of thiazide diuretics,to calcium oxalate and calcium hydrogen phosphate were de-
termined. At the conclusion of the experiment, each rat was these agents also reduce the efficiency of urinary osmotic
killed, and the kidneys, ureters, and bladder were dissected en concentration, perhaps playing a role in the prevention
block and x-rayed to determine whether any stones formed. of stone formation. There is little direct proof that super-A decrease in stone formation with a reduction in urinary
saturation itself regulates stone formation.supersaturation would support the hypothesis that supersatura-
Through successive inbreeding of the most hypercalci-tion alone can regulate stone formation.
Results. Decreasing the dietary phosphorus intake led to a uric progeny of hypercalciuric Sprague-Dawley rats, we
progressive decrease in urine phosphorus excretion and an have established a strain of rats, each of which excrete
increase in urine calcium excretion, the latter presumably
abnormally large amounts of urinary calcium [8–19]. Thecaused by decreased intestinal calcium phosphate binding and
principal mechanism for the excessive calcium excretionincreased calcium absorption. With decreasing dietary phos-
phorus intake, there was a progressive decrease in saturation in these rats appears to be an increase in intestinal cal-
cium absorption [19]. The increased intestinal calcium
absorption appears to be mediated not by an increaseKey words: hypercalciuria, renal stones, nephrolithiasis, calcium oxa-
late. in the serum level of 1,25(OH)2D3, but by an increase
in the number of intestinal vitamin D receptors [18].Received for publication May 20, 1999
When these hypercalciuric rats are fed a very low-cal-and in revised form September 17, 1999
Accepted for publication September 28, 1999 cium diet, their urine calcium excretion remains elevated
compared with that of similarly treated control rats, indi-Ó 2000 by the International Society of Nephrology
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cating a defect in renal calcium reabsorption and/or an total of 18 weeks. Each rat was offered 13 g/day of diet,
increase in bone resorption [17]. The bone from these an amount that we have previously shown is completely
hypercalciuric rats releases more calcium, compared with consumed by a female rat of this size [8]. A standard
bone of control rats, when exposed to increasing amounts 1.2% calcium, 0.65% phosphorus diet was mixed with
of 1,25(OH)2D3 [14], and inhibition of bone resorption a 1.2% calcium, 0.14% phosphorus diet (produced by
substantially decreases the hypercalciuria when these substituting chloride for most phosphorus in the standard
rats are fed a low-calcium diet [8]. In addition, a primary diet) in a ratio of 5:1, 1:1, or 1:5, resulting in a 0.565%
defect in renal calcium reabsorption is observed during phosphorus diet (termed high phosphorus), a 0.395%
carefully controlled clearance studies [12]. We have phosphorus diet (termed medium phosphorus), and a
shown that in addition to the intestine, both the bone 0.225% phosphorus diet (termed low phosphorus), re-
and kidney of the hypercalciuric rats have an increased spectively. Our goal was to decrease progressively di-
number of vitamin D receptors [10, 14, 18]. Thus, these etary phosphorus below that of the standard diet, which
hypercalciuric rats appear to have a systemic abnormality we have previously shown results in stone formation in
in calcium homeostasis. They absorb more intestinal cal- 100% of GHS rats by 18 weeks [9, 13, 15].
cium. They resorb more bone, and they fail to adequately The rats were randomly divided into three groups. Ten
reabsorb filtered calcium. As each of these hypercalciuric rats received the high-phosphorus diet, 10 the medium-
rats forms renal stones, we have termed the rats genetic phosphorus diet, and 10 the low-phosphorus diet. Every
hypercalciuric stone-forming (GHS) rats [9, 13, 15]. The two weeks, two successive 24-hour urine collections were
stones formed contain only calcium and phosphate, with- obtained. The lowered dietary phosphorus would be
out oxalate, and, by x-ray diffraction, are exclusively expected to result in a decrease in urine phosphorus
poorly crystalline apatite. Calcium transport abnormali- excretion and a decrease in urinary supersaturation with
ties similar to those documented in the GHS rats have respect to the calcium phosphate solid phase. The first
been observed in many patients with idiopathic hypercal- 24-hour urine was collected in thymol and was used for
ciuria and nephrolithiasis [2]. all measurements except oxalate, and the second 24-
In this study, we tested the hypothesis that an isolated hour collection was collected in concentrated HCl for
reduction in urine supersaturation, achieved by decreas- measurement of oxalate. Both samples were refrigerated
ing urine phosphorus excretion, would decrease stone at 08C, and biochemical measurements were determined
formation in our GHS rats. We fed the rats decreasing within two weeks. At the conclusion of the experiment
amounts of dietary phosphorus, which would be ex- (18 weeks), each rat was killed, and the kidneys, ureters,
pected to result in less urinary phosphorus and a decrease and bladder were dissected en block and mounted on
in supersaturation. We found that a decrease in urine
radiographic film. A decrease in stone formation withphosphorus excretion not only led to a decrease in urine
reduction in urinary supersaturation would support thesupersaturation with respect to the calcium phosphate
hypothesis that supersaturation alone can regulate stonesolid phase but to an elimination of renal stone forma-
formation. Any rat that ate less than 12 g of food ortion. The results of this study support the hypothesis
drank less than 15 mL of water on any day of the studythat variation in supersaturation alone can regulate renal
would have been excluded from the entire study; how-stone formation and suggest the advisability of human
ever, all rats met these prospective criteria throughoutstudies employing phosphorus restriction in patients who
the study.form calcium phosphate kidney stones.
Chemical determinations
METHODS Calcium was measured by reaction with arsenazo III
and was then determined photometrically at 650 nm [20].Establishment of hypercalciuric rats
Creatinine was determined by a modification of the JaffeAdult Sprague-Dawley rats (Charles River Labora-
method by formation of a creatinine-picrate complextories, Kingston, NY, USA) were screened for hypercal-
[21]. Inorganic phosphorus was measured by reactionciuria. The rats were placed in individual metabolic cages
with ammonium molybdate to form a colored phospho-and placed on a constant amount of a standard calcium
molybdate complex [22]. Uric acid was measured afterdiet, and the urine calcium excretion was measured. The
oxidation by uricase to produce allantoin and hydrogenmost hypercalciuric male and female rats were used to
peroxide [23]. Magnesium was determined by combina-breed the next generation. A similar protocol was used
tion with calmagite [24]. Ammonia was determined byfor screening and inbreeding of subsequent generations
coupled enzyme system using glutamate dehydrogenaseas described previously [8–19].
and NADPH [25]. Sodium was determined by a selective
Study protocol electrode [26] and potassium using a valinomycin mem-
brane attached to a potassium electrode [27]. ChlorideThirty 44th-generation female GHS rats, each initially
weighing 125 g, were placed in metabolic cages for a was measured by colorimetry using a silver/silver chlo-
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ride electrode [28]. Oxalic acid was measured using oxa- Statistical analysis
late oxidase, which oxidizes oxalate to hydrogen perox- All values are expressed as mean 6 SE. Tests of sig-
ide and carbon dioxide. The hydrogen peroxide then nificance were calculated by analysis of variance with
reacts with 3-methyl-2-benzothiazolinone hydrozone the Bonferroni correction for multiple comparisons and
and 3-(dimethyl)benzoic acid to form an indamine dye regression analysis using conventional computer pro-
[29]. Citric acid was determined using citrate lyase, which grams (BMDP; University of California, Los Angeles,
catalyzes the conversion citrate to oxaloacetic acid, CA, USA) on a digital computer. A P , 0.05 was consid-
which is then converted to malic acid, in the presence ered significant.
of malate dehydrogenase. The malic acid oxidizes
NADH to NAD1 [30]. pH was measured by an ion-
RESULTSselective electrode. Sulfate was measured by turbidity
after barium precipitation [31]. Urinary ion excretion
Every two weeks, two successive 24-hour urine collec-
Urinary supersaturation
tions were obtained. The individual urine collections for
The calcium oxalate ion activity product was calcu- the 30 rats divided equally into three groups were ana-
lated using the computer program EQUIL, which was lyzed separately and were then averaged over the first
developed by Finlayson [32–34]. The computer program six weeks (weeks 1 to 6), the second six weeks (weeks
calculates free ion concentrations using the concentra- 7 to 12), and the final six weeks (weeks 13 to 18).
tions of measured ligands and known stability constants. With respect to urine phosphorus, during each of the
Ion activity coefficients are calculated from ionic three individual six-week time periods, there was a de-
strength using the Davies modification of the Debye- crease in urine phosphorus excretion in rats eating the
Huckel solution to the Poisson-Boltzman equation. The medium-phosphorus diet compared with rats eating the
program simultaneously solves for all known binding high-phosphorus diet and a further decrease in urine
interactions among the measured substances. Oxalate, phosphorus excretion in rats eating the low-phosphorus
phosphorus, and calcium ion activities were used to cal- diet compared with rats eating the medium-phosphorus
culate the free-ion activity products. The free ions in diet; rats eating the low-phosphorus diet excreted less
solution are considered to be in an equilibrium with phosphorus than those eating the high-phosphorus diet
the dissolved calcium oxalate governed by a stability (Fig. 1, top). Thus, there was a progressive decrease in
constant (K) of 2.746 3 103 mol/L and with the dissolved phosphorus excretion with decreasing dietary phospho-
brushite governed by a K of 0.685 3 103 mol/L. The rus intake.
value of calcium oxalate in a solution at equilibrium with With respect to urine calcium, during weeks 1 to 6
a solid phase of calcium oxalate, the solubility of calcium and 7 to 12, there was an increase in urine calcium excre-
oxalate, is 6.16 3 1026 mol/L. The value of the brushite tion in rats eating the medium-phosphorus diet com-
in a solution at equilibrium with a solid phase of brushite, pared with rats eating the high-phosphorus diet, and a
the solubility of brushite, is 3.981 3 1027 mol/L. The further increase in urine calcium excretion in rats eating
relative supersaturation for calcium oxalate is calculated the low-phosphorus diet compared with rats eating the
as the ratio of the free-ion activity product of calcium medium-phosphorus diet; rats eating the low-phospho-
and oxalate in the individual urine to the solubility of rus diet excreted more calcium than those eating the
calcium oxalate. The relative supersaturation for brus- high-phosphorus diet (Fig. 1, middle). During weeks 13
hite is calculated as the ratio of the free-ion activity to 18, although there was an increase in urine calcium
product of calcium and phosphate in the individual urine excretion in rats eating the medium-phosphorus diet
to the solubility of calcium phosphate. Ratios of 1 con- compared with rats eating the high-phosphorus diet,
note a sample at equilibrium, above 1 supersaturation, there was no change in urine calcium excretion in rats
and below 1 undersaturation. eating the low-phosphorus diet compared with rats
The ability of this computer program to predict accu- eating the medium-phosphorus diet, and rats eating the
rately the saturation of urine or other solution with re- low-phosphorus diet excreted more calcium than those
spect to the solid phase is excellent [16, 17, 32, 35, 36]. eating the high-phosphorus diet. Thus, in general, there
With a series of 20 artificial solutions, the equilibrium was a progressive increase in calcium excretion with de-
calcium concentration and the extent of calcium precipi- creasing dietary phosphorus intake.
tation were predicted with average errors of 5 6 9% and With respect to urine oxalate, during each of the three
5 6 8% (mean 6 SD), respectively [32]. We have used individual six-week time periods, there was no difference
this computer program previously and found excellent in oxalate excretion between rats eating the high-,
correspondence between calculated and experimentally medium-, or low-phosphorus diet (Fig. 1, bottom). Thus,
measured saturations in urine and blood [8, 9, 11, 15–17] dietary phosphorus has no detectable effect on urine
oxalate excretion.and in bone culture medium [35–37].
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Fig. 1. Urine phosphorus, calcium, and oxa-
late excretion (mean 6 SE) in genetic hyper-
calciuric stone forming (GHS) rats fed 13
g/day of either a high-, medium-, or low-phos-
phorus diet for a total of 18 weeks. Every two
weeks, two successive 24-hour urine collec-
tions were obtained. The individual urine
collections for the 30 rats divided equally
into three groups were analyzed separately
and were then averaged over the first six
weeks (weeks 1 through 6), the second six
weeks (weeks 7 through 12), and the final
six weeks (weeks 13 through 18). Abbrevia-
tions are as follows: High, GHS rats fed 13
g/day of a 0.565% phosphorus diet; Med, GHS
rats fed 13 g/day of a 0.395% phosphorus diet;
Low, GHS rats fed 13 g/day of a 0.225% phos-
phorus diet. *Different from High, P , 0.05;
1Different from Med, P , 0.05.
With respect to urine magnesium, during each of the ence in urine magnesium excretion between rats eating
the medium- and low-phosphorus diets (Fig. 2, top).three individual six-week time periods, there was an in-
crease in urine magnesium excretion in rats eating the With respect to urine chloride, during each of the three
individual six-week time periods, there was an increasemedium- and low-phosphorus diet compared with rats
eating the high-phosphorus diet, and there was no differ- in urine chloride excretion in rats eating the medium-
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Fig. 2. Urine magnesium and chloride excre-
tion and volume (mean 6 SE) in GHS rats
fed 13 g/day of either a high-, medium-, or
low-phosphorus diet for a total of 18 weeks.
Methods and abbreviations are the same as
in Figure 1.
phosphorus diet compared with rats eating the high- dle). Thus, there was a progressive increase in chloride
excretion when dietary chloride was substitute for di-phosphorus diet, and a further increase in urine chloride
excretion in rats eating the low-phosphorus diet com- etary phosphorus.
With respect to urine volume, during each of the threepared with rats eating the medium-phosphorus diet. Rats
eating the low-phosphorus diet excreted more chloride individual six-week time periods, there was no difference
in urine volume between rats eating the low-, medium-,than those eating the high-phosphorus diet (Fig. 2, mid-
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or high-phosphorus diet, except that there was an in- CaHPO4 supersaturation with decreasing dietary phos-
phorus intake.crease in urine volume in rats eating the low compared
with those eating the high-phosphorus diet during weeks With respect to urine CaOx (calcium oxalate) super-
saturation, during weeks 1 through 6, there was a de-1 through 6 (Fig. 2, bottom).
With respect to urine sodium, during each of the three crease in CaOx supersaturation in rats fed the low-phos-
phorus diet compared with the medium-phosphorus dietindividual six-week time periods, there was no difference
in sodium excretion between rats eating the high-, (Fig. 4, bottom). During weeks 7 through 12, there was an
increase in CaOx supersaturation in rats fed the medium-medium-, or low-phosphorus diet, except that there was
an increase in urine sodium in rats eating the medium phosphorus compared with the high-phosphorus diet and
a decrease in rats fed the low-phosphorus compared withcompared with the high-phosphorus diet during weeks
1 through 6 (data not shown). Thus, dietary phosphorus the medium-phosphorus diet. During weeks 13 through
18, there were no differences in CaOx supersaturationhas little effect on urine sodium excretion.
With respect to urine pH, during weeks 1 through 6, among the three groups.
there was an increase in urine pH in rats eating the low-
Stone formationphosphorus compared with those eating the medium-
phosphorus diet (Fig. 3, top). During weeks 7 through Fifteen of the 20 kidneys from the 10 rats fed the high-
phosphorus diet had radiographic evidence of kidney12, there was an decrease in urine pH in rats eating
the low-phosphorus diet compared with those eating the stone formation, whereas no kidneys from the rats fed
either the medium or low-phosphorus diet developedhigh- and medium-phosphorus diet, and during weeks
13 through 18, there was a decrease in urine pH in rats kidney stones (Figs. 5 and 6). Ten of the 10 rats fed
the high-phosphorus diet had radiographic evidence ofeating the medium- and low-phosphorus diet compared
with those eating the high-phosphorus diet. kidney stone formation, whereas none of the rats fed
either the medium- or low-phosphorus diet developedWith respect to urine citrate, during each of the three
individual six-week time periods, there was a decrease kidney stones.
in urine citrate in rats eating the low-phosphorus diet
compared with those eating the high- and the medium-
DISCUSSIONphosphorus diet (Fig. 3, middle). Additionally, during
Genetic hypercalciuric stone-forming rats spontane-weeks 13 through 18, there was a decrease in urine citrate
ously form kidney stones when fed a normal calciumin rats eating the medium-phosphorus diet compared
(1.2%) and phosphorus (0.65%) diet [9, 13, 15]. In thiswith those eating the high-phosphorus diet.
study, we tested the hypothesis that reductions in dietaryWith respect to urine ammonium, during each of the
phosphorus would lead to reductions in urinary phospho-three individual six-week time periods, there was an in-
rus excretion and calcium phosphorus supersaturation,crease in urine ammonium excretion in rats eating the
leading to a fall in the number of stones formed. Wemedium-phosphorus diet compared with rats eating the
found that although 75% of kidneys from GHS rats fedhigh-phosphorus diet, and a further increase in urine
a 0.565% phosphorus diet contained kidney stones afterammonium excretion in rats eating the low-phosphorus
18 weeks, there was no stone formation in rats fed adiet compared with rats eating the medium-phosphorus
0.395% or a 0.225% phosphorus diet.diet. Rats eating the low-phosphorus diet excreted more
Quantitatively, the majority of intestinal phosphorusammonium than those eating the high-phosphorus diet
absorption occurs by paracellular diffusion, indicating(Fig. 3, bottom). Thus, there was a progressive increase
that a decrease in dietary phosphorus should decreasein ammonium excretion with decreasing dietary phos-
intestinal absorption, decrease the filtered load of phos-phorus intake.
phorus, and decrease urine phosphorus excretion [38,
Urinary supersaturation 39]. However, decreasing dietary phosphorus will also
lead to an increase in the rate of hydroxylation ofWith respect to urine CaHPO4 (brushite) supersatura-
25(OH)D3-1,25(OH)2D3, which will increase cell-medi-tion, during each of the three individual six-week time
ated intestinal phosphorus absorption [40]. In this study,periods, there was a decrease in urine CaHPO4 supersat-
the net result of an decrease in dietary phosphorus leduration in rats eating the medium-phosphorus diet com-
to a marked decrease in urine phosphorus excretion (Fig.pared with rats eating the high-phosphorus diet, and a
1, top). This is similar to findings in humans in whichfurther decrease in urine CaHPO4 supersaturation in rats
decreasing dietary phosphorus intake leads to an de-eating the low-phosphorus diet compared to rats eating
crease in urine phosphorus excretion [41].the medium-phosphorus diet. Rats eating the low-phos-
Alterations in dietary phosphorus should have impor-phorus diet had a lower urine CaHPO4 supersaturation
tant effects not only on urine phosphorus excretion, butcompared with those eating the high-phosphorus diet
(Fig. 4, top). Thus, there was a progressive decrease in on urinary calcium excretion. Dietary phosphorus and
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Fig. 3. Urine pH and citrate and ammonium
excretion (mean 6 SE) in GHS rats fed 13
g/day of either a high-, medium-, or low-phos-
phorus diet for a total of 18 weeks. Methods
and abbreviations are the same as in Figure 1.
calcium bind into an unabsorbable complex [42]. Thus, nal calcium absorption leading to increased urine cal-
cium excretion [43]. In the present study, a decrease inreductions in dietary phosphorus intake should result
in an increase in calcium available for absorption and dietary phosphorus led to an increase in urine calcium
(Fig. 1, middle). There was a strong inverse correlationsubsequent excretion. The phosphorus restriction in-
duced increase in 1,25(OH)2D3 will also promote intesti- between urine phosphorus and urine calcium excretion,
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addition, replacing diet phosphate with chloride has the
net effect of providing dietary calcium as CaCl2. The
presentation of calcium with chloride, rather than an
organic anion, results in intestinal chloride for bicarbon-
ate exchange with subsequent lowering of urinary pH
[47]. The fall in urine pH during the latter two time
periods would contribute to the fall in urine supersatura-
tion with respect to brushite because it would favor the
protonation of HPO45 to H2PO42, reducing the concen-
tration of HPO45 available to bind with calcium.
The decrease in urine phosphorus excretion, in spite
of an increase in urine calcium excretion, led to a marked
fall in CaHPO4 supersaturation. Kidney stones formed
in all rats fed the high-phosphorus diet and none of the
rats fed the two lower phosphorus diets. In this study,
the high-phosphorus diet led to a CaHPO4 supersatura-
tion ratio of greater than 5. Stones did not form when
the ratio was slightly less than 4, suggesting that the
critical supersaturation ratio for stone formation is some-
where between 4 and 5. Previously, we showed that
stones formed in all rats when the CaHPO4 supersatura-
tion ratio was also approximately 4, thus confirming ourFig. 4. Relative saturation ratio of brushite (CaHPO4) and calcium
current observations [15]. It is unclear why such a highoxalate (CaOx) in GHS rats fed 13 g/day of either a high-, medium-,
or low-phosphorus diet for a total of 18 weeks. The methods and supersaturation ratio is necessary for stone formation.
abbreviations are the same as in Figure 1. Possibilities include the presence of inhibitors of stone
formation, such as calgranulin [48], nephrocalcin [49],
and Tamm Horsfall protein [50], which would retard
stone formation in vivo. Citrate chelates urinary calciumsupporting the role of dietary phosphorus intake altering
not only urine phosphorus excretion, but urine calcium and is reduced in some patients with nephrolithiasis [1].
However, in this study, the small, but significant reduc-excretion as well (Fig. 7). In spite of the increased urine
calcium excretion, with no change in oxalate excretion, tion in urine citrate in the GHS rats fed the low-phos-
phate diet was not associated with stone formation. Fur-there was little change in supersaturation with respect
to the calcium oxalate solid phase. The lack of change ther studies will be necessary to investigate the role of
inhibitors in stone formation in the GHS rats.in calcium oxalate supersaturation may be due to a large
surplus of urine calcium on each of the three diets, rela- Approximately 5 to 10% of kidney stones in humans
are predominantly composed of calcium and phosphatetive to the constant amount of urine oxalate (Fig. 1,
middle and bottom). Increasing urine ionized calcium [51]. A large proportion of these patients have a renal
acidification disorder, such as complete or incompleteleads to a reciprocal decrease in urine ionized oxalate
via the formation of soluble calcium oxalate complexes, distal renal tubular acidosis, resulting in an increased
urinary pH. In these patients, there is not only a directresulting in little net change in the product of ionized
calcium and ionized oxalate, the determinant of calcium effect of acidosis to decrease renal calcium reabsorption
[52], but a component of acidosis induced bone resorp-oxalate supersaturation. In this animal model, the ratio
of calcium to oxalate is so high that much of the oxalate tion [53], resulting in hypercalciuria [54]. The elevated
pH increases the concentration of monohydrogen phos-may actually be incorporated into the soluble dicalcium
oxalate species [44, 45]. phate, which in addition to the hypercalciuria, increases
the supersaturation of calcium phosphate salts. AlkaliSimilar to calcium, dietary phosphorus complexes to
dietary magnesium [46]. In our study, at the lower levels treatment is conventionally used to correct the systemic
acidity, reduce bone resorption, reduce the hypercalci-of dietary phosphorus intake there was an increase in
urine magnesium excretion. Urine pH and urine citrate uria and reduce renal stone formation [2]. Alkali treat-
ment will also increase urinary citrate excretion, a knowntended to fall and ammonium increase at the lowest
levels of dietary phosphorus intake. This is not unex- inhibitor of stone formation [55]. However, the increased
urinary pH could promote calcium phosphate stone for-pected as the fall in urine phosphorus would make less
phosphorus available to bind protons resulting in less mation [2]. There are no controlled clinical studies to
determine whether systemic alkalinization is effective intitratable acidity and a more acidic urine, which would
stimulate renal ammonium production and excretion. In reducing renal stone formation in these patients. Other
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Fig. 5. Number of kidneys with stones ( )
and number of rats who formed stones (j).
GHS rats were fed 13 g/day of either a high-,
medium-, or low-phosphorus diet for a total of
18 weeks. Abbreviations are as follows: High,
GHS rats fed 13 g/day of a 0.565% phosphorus
diet, N 5 10; Med, GHS rats fed 13 g/day of
a 0.395% phosphorus diet, N 5 10; Low, GHS
rats fed 13 g/day of a 0.225% phosphorus diet,
N 5 10; dashed line, maximum number of
kidneys or rats with stones.
Fig. 7. Urine calcium excretion as a function of urine phosphorus
excretion in the GHS rats fed 13 g/day of either a high-, medium-, or
low-phosphorus diet for a total of 18 weeks. Every two weeks, two
successive individual 24-hour urine collections were obtained and ana-
lyzed on the 30 rats divided equally into the three groups. Symbols
are (d) GHS rats fed 13 g/day of a 0.565% phosphorus diet; (m) rats
fed 13 g/day of a 0.395% phosphorus diet; (r) GHS rats fed 13 g/day
of a 0.225% phosphorus diet (r 5 20.822, n 5 289, P , 0.001).
therapeutic modalities such as thiazide diuretic treat-
ment to reduce hypercalciuria or reduction of dietary
phosphorus to reduce urinary phosphorus excretion have
not been studied. This study, performed in nonacidemic
hypercalciuric rats suggests that phosphorus restriction
might be beneficial in preventing stones in patients, such
as those with renal tubular acidosis, who develop calcium
phosphate nephrolithiasis. Controlled studies in patients
who form calcium phosphate stones are indicated before
this therapy can be recommended.
Thus, we have found that stone formation in GHS rats
is critically dependent on dietary phosphorus intake and
the resulting change in urinary phosphorus excretion
and calcium phosphate supersaturation. A reduction in
urinary supersaturation leads to an amelioration of stone
Fig. 6. Radiograph of stone formation in a representative GHS rat formation in this rat model of idiopathic hypercalciuria.
demonstrating nephrolithiasis in both kidneys. Radiographs were ob- Further studies in which humans with renal tubular aci-tained by placing the dissected kidneys, ureters, and bladder on radio-
graphic film, and no contrast material was used. dosis or idiopathic hypercalciuria are given graded
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